We also found that pantoprazole inhibits the activation of the JAK2/STAT3 pathway and that a higher concentration of pantoprazole treatment displayed better efficacy in treating the muscle wasting induced by cancer cachexia by regulating the JAK2/STAT3 pathway. The gene discussed is JAK2; the disease is cancer.